{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:29:41Z","timestamp":1789655381972,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872820"],"award-info":[{"award-number":["81872820"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-MS-192"],"award-info":[{"award-number":["2020-MS-192"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jconrel.2023.01.075","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T17:40:30Z","timestamp":1675791630000},"page":"211-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation"],"prefix":"10.1016","volume":"355","author":[{"given":"Ming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.01.075_bb0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-019-08595-2","article-title":"Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer","volume":"10","author":"Merino","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0010","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1718197115","article-title":"Chemotherapy induces enrichment of CD47+\/CD73+\/PD-L1+ immune evasive triple-negative breast cancer cells","volume":"115","author":"Samanta","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0015","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative breast cancer: disease entity or title of convenience?","volume":"7","author":"Carey","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2017.07.002","article-title":"Immunotherapy for triple-negative breast cancer: existing challenges and exciting prospects","volume":"32","author":"Jia","year":"2017","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0025","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1021\/acsnano.7b09112","article-title":"Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication","volume":"12","author":"Song","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0030","first-page":"1365","article-title":"High-density lipoprotein-mimicking Nanodiscs for chemo-immunotherapy against glioblastoma Multiforme","volume":"13","author":"Kadiyala","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell\u2013mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt0415-321","article-title":"IDO inhibitors move center stage in immuno-oncology","volume":"33","author":"Sheridan","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0045","first-page":"143","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment, nature reviews","volume":"13","author":"Smyth","year":"2016","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0055","doi-asserted-by":"crossref","first-page":"1801868","DOI":"10.1002\/advs.201801868","article-title":"Tumors and their microenvironment dual-targeting chemotherapy with local immune adjuvant therapy for effective antitumor immunity against breast Cancer","volume":"6","author":"Deng","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120546","article-title":"Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment","volume":"268","author":"Zhou","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120604","article-title":"Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy","volume":"269","author":"Qiu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2022.01.002","article-title":"Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy","volume":"342","author":"Geng","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0075","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1021\/acsnano.8b01890","article-title":"Nanocarrier-mediated chemo-immunotherapy arrested Cancer progression and induced tumor dormancy in desmoplastic melanoma","volume":"12","author":"Liu","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0080","doi-asserted-by":"crossref","first-page":"46361","DOI":"10.1021\/acsami.1c14170","article-title":"Multifunctional size-expandable nanomedicines enhance tumor accumulation and penetration for synergistic chemo-Photothermal therapy","volume":"13","author":"Li","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0085","doi-asserted-by":"crossref","first-page":"1805888","DOI":"10.1002\/adma.201805888","article-title":"Tumor microenvironment-Activatable prodrug vesicles for Nanoenabled Cancer Chemoimmunotherapy combining immunogenic cell death induction and CD47 blockade","volume":"31","author":"Zhou","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0090","doi-asserted-by":"crossref","first-page":"1803001","DOI":"10.1002\/adma.201803001","article-title":"Binary cooperative prodrug nanoparticles improve immunotherapy by synergistically modulating immune tumor microenvironment","volume":"30","author":"Feng","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0095","doi-asserted-by":"crossref","first-page":"1802228","DOI":"10.1002\/adma.201802228","article-title":"Nanoparticle-enhanced radiotherapy to trigger robust Cancer immunotherapy","volume":"31","author":"Chen","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1126\/science.aaa8172","article-title":"The future of immune checkpoint therapy","volume":"348","author":"Sharma","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","article-title":"Immune checkpoint targeting in Cancer therapy: toward combination strategies with curative potential","volume":"161","author":"Sharma","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0110","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0115","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.09.008","article-title":"Emerging concepts for immune checkpoint blockade-based combination therapies","volume":"34","author":"Zappasodi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0120","doi-asserted-by":"crossref","first-page":"1902960","DOI":"10.1002\/adma.201902960","article-title":"Self-amplified drug delivery with light-inducible Nanocargoes to enhance Cancer immunotherapy","volume":"31","author":"Feng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0125","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","article-title":"CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy","volume":"572","author":"Barkal","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0130","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3389\/fimmu.2020.01324","article-title":"Molecular mechanism of tumor cell immune escape mediated by CD24\/Siglec-10","volume":"11","author":"Yin","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0135","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1021\/acsnano.1c10921","article-title":"Targeted intervention of NF2\u2013YAP signaling Axis in CD24-overexpressing cells contributes to encouraging therapeutic effects in TNBC","volume":"16","author":"Hou","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2017.08.028","article-title":"Identification of a novel single chain fragment variable antibody targeting CD24-expressing Cancer cells","volume":"190","author":"Eyvazi","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0145","doi-asserted-by":"crossref","first-page":"16030","DOI":"10.1021\/acsnano.1c04458","article-title":"A siRNA-assisted assembly strategy to simultaneously suppress \u201cSelf\u201d and upregulate \u201cEat-Me\u201d signals for Nanoenabled chemo-immunotherapy","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0150","doi-asserted-by":"crossref","first-page":"2004853","DOI":"10.1002\/adma.202004853","article-title":"Activating macrophage-mediated Cancer immunotherapy by genetically edited nanoparticles","volume":"32","author":"Rao","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0155","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-018-04567-0","article-title":"The homeobox protein VentX reverts immune suppression in the tumor microenvironment","volume":"9","author":"Le","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","article-title":"Immune suppressive mechanisms in the tumor microenvironment","volume":"39","author":"Munn","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0165","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1021\/acs.nanolett.0c01287","article-title":"Functional Gadofullerene nanoparticles trigger robust Cancer immunotherapy based on rebuilding an immunosuppressive tumor microenvironment","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13058-015-0621-0","article-title":"Human breast cancer cells educate macrophages toward the M2 activation status","volume":"17","author":"Sousa","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.12659\/MSM.895386","article-title":"Expression of tumor-related macrophages and cytokines after surgery of triple-negative breast Cancer patients and its implications","volume":"22","author":"Wang","year":"2016","journal-title":"Med. Sci. Monit.\u202f: Int. Med. J. Experiment. Clin. Res."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bioactmat.2021.12.033","article-title":"Polarization of tumor-associated macrophages by TLR7\/8 conjugated radiosensitive peptide hydrogel for overcoming tumor radioresistance","volume":"16","author":"Zhang","year":"2022","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0185","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41467-019-11911-5","article-title":"Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0190","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1021\/acsnano.7b05465","article-title":"Molecular-targeted immunotherapeutic strategy for melanoma via dual-targeting nanoparticles delivering small interfering RNA to tumor-associated macrophages","volume":"11","author":"Qian","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0195","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","article-title":"Macrophages and therapeutic resistance in Cancer","volume":"27","author":"Ruffell","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0200","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41467-017-01919-0","article-title":"Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability","volume":"8","author":"Gao","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0205","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.bioactmat.2021.02.008","article-title":"HIF1\u03b1 epigenetically repressed macrophages via CRISPR\/Cas9-EZH2 system for enhanced cancer immunotherapy","volume":"6","author":"Dong","year":"2021","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0210","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jconrel.2021.05.036","article-title":"Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction","volume":"335","author":"Zhao","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0215","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.canlet.2018.11.011","article-title":"Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity","volume":"442","author":"Yu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0220","doi-asserted-by":"crossref","first-page":"1904337","DOI":"10.1002\/adma.201904337","article-title":"Recent advances in Nanostrategies capable of overcoming biological barriers for tumor management","volume":"32","author":"Huo","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0225","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1021\/acsnano.8b03900","article-title":"Quantifying the ligand-coated nanoparticle delivery to Cancer cells in solid tumors","volume":"12","author":"Dai","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0230","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1021\/acs.nanolett.8b03174","article-title":"Near-infrared laser-driven in situ self-assembly as a general strategy for deep tumor therapy","volume":"18","author":"Liu","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0235","doi-asserted-by":"crossref","first-page":"538","DOI":"10.7150\/thno.16684","article-title":"Current multistage drug delivery systems based on the tumor microenvironment","volume":"7","author":"Chen","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.03.012","article-title":"Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles","volume":"277","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0245","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2018.03.046","article-title":"Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy","volume":"168","author":"Hu","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.01.075_bb0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in Cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.01.075_bb0265","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.cell.2020.01.005","article-title":"Augmenting immunotherapy impact by lowering tumor TNF cytotoxicity threshold","volume":"180","author":"Vredevoogd","year":"2020","journal-title":"Cell"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:39:23Z","timestamp":1759163963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"alternative-id":["S0168365923000846"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.075","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering nanoparticles boost TNBC therapy by CD24 blockade and mitochondrial dynamics regulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}